Mohammed Abbas, SALES,MARKETING,BUSINESS Development director

Mohammed Abbas

SALES,MARKETING,BUSINESS Development director

DELTA--EGPI-UNIPHARMA -DBK PHARMA

Location
Egypt - Cairo
Education
Bachelor's degree, Faculty of pharmacy /
Experience
24 years, 0 Months

Share My Profile

Block User


Work Experience

Total years of experience :24 years, 0 Months

SALES,MARKETING,BUSINESS Development director at DELTA--EGPI-UNIPHARMA -DBK PHARMA
  • Egypt - Cairo
  • My current job since August 2000

1- Sales increased from 2.5 Million / 2001 to 186 Million / 2009.
2- Delta Pharma became No.12 in the sold unit till 6/2010 (YTD) with 61% Growth
(No.1 in the Egyptian Ph.Co.).
3- Delta Pharma became No.21 in sales Vol. (L.E.) with Gr% 46% ( No.2 )
4- Dolphin family brand name became No.1 (Sold unit) in NSAID segment.
5- Dolphin Ped.suppositories became No.1 as analgesic & anti inflammatory with more than 13 Million Box / year.
6- Navoproxin became No.1 in the segment of antiemetic according to I.MS data (Cyclizine & Meclizine gp.).
7- Glimadel became No.5 as oral antidiabetics
8- Desa (after 2 years from its launch) became No.12 in oral antihist.
9- Rovac became No.8 oral antibiotic in macrolides gp.
10- I built & organized a powerful & strong organization with ability to compete
With any other company & products.
11- I started the successful participation for export to morchious, Yemen, Libya.

BUSINESS DEVELOPMENT DIRECTOR at MANAGING 6 EGYPTIAN CO,S
  • Egypt - Cairo
  • October 2000 to August 2010

1- Sales increased from 2.5 Million / 2001 to 186 Million / 2009.
2- Delta Pharma became No.12 in the sold unit till 6/2010 (YTD) with 61% Growth
(No.1 in the Egyptian Ph.Co.).
3- Delta Pharma became No.21 in sales Vol. (L.E.) with Gr% 46% ( No.2 )
4- Dolphin family brand name became No.1 (Sold unit) in NSAID segment.
5- Dolphin Ped.suppositories became No.1 as analgesic & anti inflammatory with more than 13 Million Box / year.
6- Navoproxin became No.1 in the segment of antiemetic according to I.MS data (Cyclizine & Meclizine gp.).
7- Glimadel became No.5 as oral antidiabetics
8- Desa (after 2 years from its launch) became No.12 in oral antihist.
9- Rovac became No.8 oral antibiotic in macrolides gp.
10- I built & organized a powerful & strong organization with ability to compete
With any other company & products.
11- I started the successful participation for export to morchious, Yemen, Libya.

Consultant at Holdi pharma Co. (Memphis Co.)
  • Egypt - Cairo
  • June 2000 to October 2000

provide all requirments of consultation for the sales & marketing Departments

Education

Bachelor's degree, Faculty of pharmacy /
  • at B. Pharmaceutical SC.
  • June 1984

then i have got a lot of training courses & m-MBA IN MARKETING & HR

Specialties & Skills

Marketing Solutions
Business Change Management
Business Development Manager
HR Management
HR & BUSINESS DEVELOPMENT
SALES & MARKETING
SALES & MARKETING
SALES & MARKETING

Languages

English
Expert

Memberships

egyptian pharmaceutical socity & syndicate
  • active member
  • July 1984

Training and Certifications

CERTIFICATES FOR ALL COURSES ARE AVAILABLE (Certificate)
Date Attended:
November 1988
Valid Until:
December 2010